It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.
Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...
Scotiabank raised the firm’s price target on Thermo Fisher (TMO) to $650 from $605 and keeps a Sector Perform rating on the shares. The ...
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
Raymond James analyst Andrew Cooper maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $667.00.
State and local officials are seeking permission from the Wisconsin Legislature to offer additional financial incentives to ...
Thermo Fisher Scientific is cutting 300 employees across two viral vector manufacturing facilities in Massachusetts, marking ...
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
The American biomedical company Thermo Fisher describes a prominent product featured on its website, the RapidHIT ID system, ...